Take Charge – Patient Conference 2021

This event was held in 2021 but you can still watch the recording. Fill out the form below to be taken to the video recordings. Please save the recording pages if you wish to revisit and watch in the future.

About the event

We held our first Patient Symposium on 15 September 2021. This event is for patients and carers to access relevant and up to date information from a variety of health care professionals.
All patients and carers are encouraged to watch the recorded sessions as you will find the information relevant, regardless of where you are in your journey.

Topics discussed include:
  • navigating the health care system
  • right treatment right time?
  • complementary and alternative therapies
  • survivorship, and
  • emotional wellbeing.
 
 

Download the 2021 Patient Conference flyer here

Download the 2021 Patient Conference detailed agenda here

Contact Lymphoma Australia Today!

Please note:
Lymphoma Australia staff are only able to reply to emails sent in English language.

Useful Definitions

  • Refractory: This means the lymphoma does not get better with treatment. The treatment didn’t work as hoped.
  • Relapsed: This means the lymphoma came back after being gone for a while after treatment.
  • 2nd line treatment: This is the second treatment you get if the first one didn’t work (refractory) or if the lymphoma comes back (relapse).
  • 3rd line treatment: This is the third treatment you get if the second one didn’t work or the lymphoma comes back again.
  • Approved: Available in Australia and listed by the Therapeutics Goods Administration (TGA).
  • Funded: Costs are covered for Australian citizens. This means if you have a Medicare card, you shouldn’t have to pay for the treatment.[WO7]

You need healthy T-cells to make CAR T-cells. For this reason, CAR T-cell therapy cannot be used if you have a T-cell lymphoma – yet.

For more information on CAR T-cells and T-cell lymphoma click here. 

Special Note: Although your T-cells are removed from your blood for CAR T-cell therapy, most of our T-cells live outside of our blood – in our lymph nodes, thymus, spleen and other organs.